ZD-2138
Phase 2- Indications
- Asthma, Rhinitis
Company intelligence / Profile preview
Biolipox AB
Stockholm or Uppsala region, Swedenir.neurogene.com ↗
- Ownership
- Private
- Employees
- ~52
- Development stage
- Phase 2
01
Overview
Biolipox was a Swedish pharmaceutical R&D company specializing in novel anti-inflammatory drugs for respiratory and inflammatory diseases. Its scientific foundation was world-class research into the arachidonic acid pathway at the Karolinska Institute. The company developed a broad portfolio targeting asthma, COPD, rhinitis, pain, and arthritis. It had several programs advancing through preclinical to Phase II trials before being acquired by Orexo AB in November 2007. Clinical results included completion of a Phase II trial for an allergic rhinitis nasal spray.
- Therapeutic areas
- PulmonologyImmunologyRheumatology
- Modalities
- Small molecules (focus on anti-inflammatory therapeutics targeting arachidonic acid metabolism)Nasal spray formulationsLiposomal drug delivery (e.g., Cetirizine Hydrochloride Liposomal)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Axovan AG—collaboration focused on GPCR drug targetsInflazyme Pharmaceuticals Ltd.—asset purchase agreement for respiratory/inflammatory disease programs
Beyond the preview
Go deeper on Biolipox AB.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biolipox AB.